ZTSNYSEPharmaceutical PreparationsFiscal year ends December 31
Zoetis Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 6, 2026
$79.59+0.21 (+0.26%)
Close on Oct 19, 2026
- Market cap
- $33.24B
- P/E (TTM)
- 13.1
- Dividend yield
- 2.55%
Zoetis statistics
Financials through Jun 30, 2026, price as of Oct 19, 2026, median of Pharmaceutical Preparations companies for comparison
Valuation
| Measure | Zoetis | Industry median |
|---|---|---|
| Market Cap | $32.89B | $197.05M |
| Enterprise Value | $40.26B | $106.56M |
| PE Ratio | 13.09 | 20.52 |
| PS Ratio | 3.46 | 3.93 |
| PB Ratio | 10.45 | 2.14 |
| P/FCF Ratio | 14.20 | 18.25 |
| P/OCF Ratio | 11.58 | 13.78 |
Enterprise value
| Measure | Zoetis | Industry median |
|---|---|---|
| EV / Sales | 4.23 | 2.69 |
| EV / EBITDA | 10.08 | 14.86 |
| EV / FCF | 17.38 | 21.02 |
Income (trailing twelve months)
| Measure | Zoetis | Industry median |
|---|---|---|
| Revenue | $9.52B | $57.94M |
| Gross Profit | $6.81B | $90.47M |
| Pretax Income | $3.27B | -$14.45M |
| Net Income | $2.62B | -$22.46M |
| EBITDA | $3.99B | -$16.91M |
| EPS (Diluted) | $6.08 | -$0.83 |
Margins
| Measure | Zoetis | Industry median |
|---|---|---|
| Gross Margin | 71.5% | 52.3% |
| Pretax Margin | 34.4% | -13.0% |
| Profit Margin | 27.5% | -39.2% |
| EBITDA Margin | 42.0% | -31.3% |
| FCF Margin | 24.3% | -8.85% |
Returns
| Measure | Zoetis | Industry median |
|---|---|---|
| Return on Equity (ROE) | 64.4% | -53.1% |
| Return on Assets (ROA) | 17.7% | -41.0% |
Growth
| Measure | Zoetis | Industry median |
|---|---|---|
| Revenue Growth (YoY) | 1.49% | 6.01% |
| Net Income Growth (YoY) | 0.96% | -37.7% |
| EPS Growth (YoY) | 5.56% | -29.2% |
| FCF Growth (YoY) | 2.07% | 2.34% |
| Revenue Growth (3Y CAGR) | 5.42% | 2.25% |
| Revenue Growth (5Y CAGR) | 7.24% | 6.42% |
| EPS Growth (3Y CAGR) | 10.3% | -0.17% |
| EPS Growth (5Y CAGR) | 12.0% | 3.77% |
Balance sheet
| Measure | Zoetis | Industry median |
|---|---|---|
| Cash & Short-Term Investments | $1.68B | $62.42M |
| Total Debt | $9.05B | $120.13M |
| Net Cash (Debt) | -$7.37B | $15.68M |
| Net Cash Per Share | -$17.84 | $0.65 |
| Equity (Book Value) | $3.15B | $48.79M |
| Book Value Per Share | $7.62 | $1.36 |
| Tangible Book Value | -$541.00M | $23.06M |
| Working Capital | $4.30B | $75.77M |
Financial position
| Measure | Zoetis | Industry median |
|---|---|---|
| Current Ratio | 3.08 | 3.30 |
| Quick Ratio | 1.58 | 2.39 |
| Debt / Equity | 2.87 | 0.51 |
| Debt / EBITDA | 2.27 | 3.35 |
| Debt / FCF | 3.91 | 5.05 |
| Net Debt / EBITDA | 1.85 | 2.22 |
Cash flow (trailing twelve months)
| Measure | Zoetis | Industry median |
|---|---|---|
| Operating Cash Flow | $2.84B | -$12.35M |
| Capital Expenditures | -$524.00M | -$1.06M |
| Free Cash Flow | $2.32B | -$20.28M |
| FCF Per Share | $5.60 | -$0.41 |
Efficiency
| Measure | Zoetis | Industry median |
|---|---|---|
| Asset Turnover | 0.64 | 0.38 |
| Inventory Turnover | 1.08 | 2.67 |
| Revenue Per Employee | $656.35K | $398.96K |
| Profits Per Employee | $180.41K | -$732.08K |
| Employee Count | 14,500 | 73 |
Dividends and yields
| Measure | Zoetis | Industry median |
|---|---|---|
| Earnings Yield | 7.95% | -21.2% |
| FCF Yield | 7.04% | -7.64% |
| Dividend Yield | 2.55% | 1.83% |
| Buyback Yield | 11.1% | -0.58% |
| Shareholder Yield | 13.6% | 0.00% |
| Dividend Per Share | $2.03 | $0.83 |
| Dividend Growth (YoY) | 13.0% | 2.37% |
| Years of Dividend Growth | 11 | 0 |
Shares
| Measure | Zoetis | Industry median |
|---|---|---|
| Shares Outstanding | 413,224,000 | 59,128,900 |
| Shares Change (YoY) | -4.24% | 11.1% |
| Shares Change (QoQ) | -1.47% | 0.54% |
| Float | 412,895,000 | 48,744,500 |
| Shares Held by Insiders | 0.08% | 11.8% |
| Shares Held by Institutions | 96.1% | 59.4% |
Taxes
| Measure | Zoetis | Industry median |
|---|---|---|
| Income Tax | $656.00M | $91.50K |
| Effective Tax Rate | 20.0% | 20.6% |
Scores
| Measure | Zoetis | Industry median |
|---|---|---|
| Graham Number | $32.28 | $17.36 |
| Graham Upside | -59.4% | -45.5% |
| Altman Z-Score | 3.99 | 0.10 |
| Piotroski F-Score | 8 | 4 |
| Beneish M-Score | -2.57 | -2.62 |
Calculated by StockData from Zoetis's SEC filings and the latest closing price. Hover a measure to see its formula. The grey column is the median of companies in the same industry group (two-digit SIC code); green or red marks a better or worse value than that median.